| Ruth S Shealy, NP | |
|
22580 Highway 76 E, Suite 100, Laurens, SC 29360-8439 | |
| (864) 833-5986 | |
| (864) 833-0599 |
| Full Name | Ruth S Shealy |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Gerontology |
| Location | 22580 Highway 76 E, Laurens, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750329694 | NPI | - | NPPES |
| NP0617 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | 29093 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ruth S Shealy, NP 22580 Highway 76 E, Suite 100, Laurens, SC 29360-8439 Ph: (864) 833-5986 | Ruth S Shealy, NP 22580 Highway 76 E, Suite 100, Laurens, SC 29360-8439 Ph: (864) 833-5986 |
News Archive
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
Dr. Susan Wong sat down with an 84-year-old patient in the hospital, where he'd been admitted with a flare-up of a serious autoimmune condition and deteriorating kidney function.
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
› Verified 8 days ago
Alexandrea Cromer Broom, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22580 Highway 76 E Ste 300, Laurens, SC 29360 Phone: 864-939-1070 Fax: 864-939-1079 | |
Lorraine M Archer, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Tiffany Goggans, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Amy Ledford Strickland, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22580 Highway 76 E Ste 300, Laurens, SC 29360 Phone: 864-939-1070 Fax: 864-939-1079 | |
Cathy L Merrell, F.N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Mrs. Stephanie Powers Mccall, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 106 Parkview Dr, Laurens, SC 29360 Phone: 864-984-0571 Fax: 864-984-3610 | |
Mrs. Gina Alexander Berrios, APRN, FNP-C, ANP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1108 Church St, Laurens, SC 29360 Phone: 803-924-6093 Fax: 864-682-1234 |